Bibliography
Found 17 results
Filters: Author is S E Panos [Clear All Filters]
. Neurocognition and Medication Adherence in HIV-Infected Adults. In: Social Neuroscience and Health. 2013th ed. Social Neuroscience and Health. Springer Publications; 2013. pp. 85-108.
. Cross-section effects of APOE E4 by Discrete Neurocognitive Domain. In: 40th Annual Conference of the International Neuropsychological Society. 40th Annual Conference of the International Neuropsychological Society. ; 2012.
. Cross-sectional and longitudinal studies of medication adherence and cognition among HIV+ adults. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Gray matter atrophy among older adults with HIV: The effects of age and disease status. In: 9th annual meeting of the American Academy of Clinical Neuropsychology. 9th annual meeting of the American Academy of Clinical Neuropsychology. Washington, DC; 2010.
. HIV and Aging: The interactive effects of aging and cocaine use on neurocognition. In: International Neuropsychological Society’s 39th Annual Meeting. International Neuropsychological Society’s 39th Annual Meeting. Boston, MA; 2011.
. The Interplay between APOE EF, Disease Severity, and Cognition. In: 92nd Annual Conference of the Western Psychological Association. 92nd Annual Conference of the Western Psychological Association. ; 2012.
. Longitudinal changes in medication adherence among HIV+ adults: Relationship with neurocognition and changes in psychiatric functioning. In: 29th annual meeting of the National Academy of Neuropsychology. 29th annual meeting of the National Academy of Neuropsychology. New Orleans, Louisiana; 2009.
. Longitudinal Changes in Medication Adherence among HIV-infected adults: A Hierarchical Linear Modeling Approach. In: 9th annual conference of the American Academy of Clinical Neuropsychology. 9th annual conference of the American Academy of Clinical Neuropsychology. ; 2011.
. Longitudinal effects of APOE e4 on HIV-Associated Neurocognitive Dysfunction. In: Annual Meeting of the International Neuropsychological Society. Annual Meeting of the International Neuropsychological Society. ; 2012.
. Predictors of longitudinal medication adherence: Evidence from an integrative model. In: 9th annual meeting of the American Academy of Clinical Neuropsychology. 9th annual meeting of the American Academy of Clinical Neuropsychology. ; 2011.
Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehavioral HIV Medicine [Internet]. 2013 ;Volume 2013:5:11-22. Available from: http://www.dovepress.com/apolipoprotein-e-genotype-and-human-immunodeficiency-virus-associated--peer-reviewed-article-NBHIV
. Cognitive reserve masks the neurobehavioral expression of HIV neurological disorder in older adults. Neurobehavioral HIV Medicine. 2011 ;3:87-93.
. The impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal models. AIDS Care [Internet]. 2014 ;26(1):79-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23756102
. Past stimulant abuse is associated with basal ganglia and hippocampal integrity in older HIV+ adults: A Diffusion Tensor Imaging study. Journal of AIDS and Clinical Research. 2011 ;2:128-133.
